离岸价格
Get Latest Price( Negotiable )
|100 Gram Minimum Order
国:
China
モデル番号:
IP0004-C
离岸价格:
( Negotiable ) Get Latest Price
ロケーション:
china
最低注文量の価格:
-
最低注文量:
100 Gram
パッケージの詳細:
Aluminum foil bag, PTFE Bottle, or meet your requirment
納期:
Within one week
供給能力:
1 Kilogram per Month
支払いタイプ:
D/P, L/C, T/T
製品グループ :
連絡先担当者 Mr. James
Building A, NO.688,Qiushi Road,Jinshan District, Shanghai, shanghai
Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug is being investigated as a single dose therapy, as well as in combination with chemotherapy.Pfizer submitted a new drug application for the treatment of advanced renal cell carcinoma based on the Phase III AXIS ***2 trial.The drug has been approved for review by the FDA in June ***1.The drug was also accepted for review by the European Medicines Agency in June ***1.The review will be based on the Phase III AXIS ***2 trial.More than **0,**0 people are diagnosed with renal cell carcinoma every year and **2,**0 people die as a result of the cancer.
| 国: | China |
| モデル番号: | IP0004-C |
| 离岸价格: | ( Negotiable ) Get Latest Price |
| ロケーション: | china |
| 最低注文量の価格: | - |
| 最低注文量: | 100 Gram |
| パッケージの詳細: | Aluminum foil bag, PTFE Bottle, or meet your requirment |
| 納期: | Within one week |
| 供給能力: | 1 Kilogram per Month |
| 支払いタイプ: | D/P, L/C, T/T |
| 製品グループ : | Pharma intermediate |
